Cytokinetics Inc (CYTK) 재무 분석
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues | 66.14%47.56 | 28.62 | 19.36 | 17.76 | 1.94 |
3.30%214.65 | 207.80 | 202.97 | 196.12 | 168.69 | |
| Selling, General, and Administrative | 8.38%113.14 | 104.40 | 104.90 | - | - |
| Research and Development | 1.51%99.29 | 97.81 | 95.53 | 104.40 | 99.23 |
| Operating Income/Loss | 6.74%-167.09 | -179.17 | -183.62 | -178.37 | -166.76 |
| Nonoperating Income/Loss | 14.07%15.90 | 13.94 | 11.02 | 11.47 | 10.25 |
4.37%-190.07 | -198.76 | -206.03 | -183.03 | -306.18 | |
| Attributable To Parent | 4.37%-190.07 | -198.76 | -206.03 | -183.03 | -306.18 |
| Basic Average Shares | 5.27%0.14 | 0.13 | 0.12 | 0.00 | 0.12 |
| Diluted Average Shares | 5.27%0.14 | 0.13 | 0.12 | 0.00 | 0.12 |
| Basic Earnings Per Share | 8.67%-1.37 | -1.50 | -1.67 | -1.50 | -2.55 |
| Diluted Earnings Per Share | 8.67%-1.37 | -1.50 | -1.67 | -1.50 | -2.55 |